EAM
TNYA icon

Empery Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

Empery Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.97M Sell
4,286,933
-1,127,168
-21% -$832K 3.58% 6
2025
Q4 		$3.85M Buy
+5,414,101
New +$7.36M 3.4% 7

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Empery Asset Management's TNYA Position: Q1 2026 in Review

Empery Asset Management reduced its Tenaya Therapeutics (TNYA) stake by 21% in Q1 2026, selling an estimated $832K and leaving 4,286,933 shares worth $2.97M. The position accounts for 3.58% of the portfolio, ranked #6.

Empery Asset Management first reported a position in TNYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.85M in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Empery Asset Management held 4,286,933 shares of Tenaya Therapeutics worth $2.97M as of Q1 2026.
  • Empery Asset Management sold 1,127,168 Tenaya Therapeutics shares in Q1 2026, an estimated $832K.
  • Tenaya Therapeutics made up 3.58% of Empery Asset Management's portfolio in Q1 2026, its #6 holding.
  • Empery Asset Management first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Empery Asset Management's Tenaya Therapeutics position peaked at $3.85M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Empery Asset Management's 13F filing for Q1 2026, filed 8 May 2026.